LYB
32
3
CMG
47
-3
M
33
8
JNPR
63
5
MOS
48
5
ORCL
56
4
KMI
81
6
CMI
52
11
CAG
55
2
BAX
45
-3
AEE
84
2
AMG
60
8
PGR
70
3
PX
50
5
C
53
3
HBI
61
13
GD
50
2
DFS
42
-18
PRGO
51
7
JCI
47
3
LYB
32
3
CMG
47
-3
M
33
8
JNPR
63
5
MOS
48
5
ORCL
56
4
KMI
81
6
CMI
52
11
CAG
55
2
BAX
45
-3
AEE
84
2
AMG
60
8
PGR
70
3
PX
50
5
C
53
3
HBI
61
13
GD
50
2
DFS
42
-18
PRGO
51
7
JCI
47
3
Financhill
Back

ProShares Short 20+ Yr Treasury Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
45

TBF
ProShares Short 20+ Yr Treasury

Last Price:
$23.82
Seasonality Move:
-2.33%
Sell
19

CRSP
CRISPR Therapeutics AG

Last Price:
$40.99
Seasonality Move:
6.36%
Sell
45
ProShares Short 20+ Yr Treasury (TBF) is a Sell

Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?

  • The current ProShares Short 20+ Yr Treasury [TBF] share price is $23.86. The Score for TBF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • TBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $42.82. The Score for CRSP is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TBF Stock Price Chart

What is ProShares Short 20+ Yr Treasury's stock price today?

  • The ProShares Short 20+ Yr Treasury share price today is $23.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBF is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $42.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight buying pressure.

TBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 47.75 Sell
Chaikin Money Flow: 46463 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.62 - 24.34) Sell
Bollinger Bands (100): (23.49 - 24.59) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 47.3 Sell
Chaikin Money Flow: 525208 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.67 - 47.89) Sell
Bollinger Bands (100): (40.95 - 49.55) Sell

TBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.88 Sell
20-day SMA: 23.89 Sell
50-day SMA: 24.33 Sell
200-day SMA: 23.49 Buy
8-day EMA: 23.86 Buy
20-day EMA: 23.92 Sell
50-day EMA: 24.06 Sell
200-day EMA: 23.72 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.18 Sell
20-day SMA: 45.22 Sell
50-day SMA: 42.69 Buy
200-day SMA: 48.66 Sell
8-day EMA: 43.07 Sell
20-day EMA: 43.65 Sell
50-day EMA: 43.83 Sell
200-day EMA: 48.31 Sell

ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.

ProShares Short 20+ Yr Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):